Leuven, Belgium

G Van Asche

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: G Van Asche. Retrieved from https://idiyas.com/inventor/g-van-asche

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:

goldMedal1 out of 834,601 
Other
 patents

Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: G Van Asche: Innovator in Gastrointestinal Treatments

Introduction

G Van Asche is a notable inventor based in Leuven, Belgium. She has made significant contributions to the field of medicine, particularly in the treatment of gastrointestinal disorders. Her innovative approach has led to the development of a unique patent that addresses critical health issues.

Latest Patents

G Van Asche holds a patent for the "Use of interleukin-11 to treat gastrointestinal disorders." This patent discloses the use of interleukin-11 to prevent, ameliorate, and treat gastrointestinal disorders in mammals in need of such treatment. This groundbreaking work has the potential to improve the quality of life for many individuals suffering from these conditions.

Career Highlights

Throughout her career, G Van Asche has demonstrated a commitment to advancing medical science. Her research and innovations have garnered attention in the medical community, showcasing her dedication to improving health outcomes.

Collaborations

G Van Asche has collaborated with esteemed colleagues, including James C Keith, Jr. and Theo L Peeters. These partnerships have further enriched her research and contributed to the success of her innovations.

Conclusion

G Van Asche's work in the field of gastrointestinal treatments exemplifies the impact of innovative thinking in medicine. Her patent on interleukin-11 represents a significant advancement in the treatment of gastrointestinal disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…